CLINICAL_TRIALS
trial_result
· 2016-01-11
Clinical Trial Update: A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia [Phase 4]
Summary
Phase 4 study of Bonviva (ibandronate) given monthly in postmenopausal osteopenia completed. Results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Post-Menopausal Osteopenia | Phase 4 | Status: COMPLETED | Results posted: 2016-01-11